Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation

References

• Jaeken J. Congenital disorders of glycosylation. Ann N Y Acad Sci 2010;1214:190-8
   PubMed Web of Science ®Google Scholar
• Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 2011;21(5):576-82
   PubMed Web of Science ®Google Scholar
• Jaeken J, Hennet T, Matthijs G, Freeze HH. CDG nomenclature: time for a change!. Biochim Biophys Acta 2009;1792(9):825-6
   PubMed Web of Science ®Google Scholar
• Jaeken J, Vanderschueren-Lodewyckx M, Snoeck L, et al. Familiar psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediar Res 1980;14(2):179
   Web of Science ®Google Scholar
• Freeze HH. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 2013;288(10):6936-45
   PubMed Web of Science ®Google Scholar
• Vermeer S, Kremer HP, Leijten QH, et al. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening. J Neurol 2007;254(10):1356-8
   PubMed Web of Science ®Google Scholar
• Basiri K, Belaya K, Liu WW, et al. Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1. Neuromuscul Disord 2013;23(6):469-72
   PubMed Web of Science ®Google Scholar
• Rafiq MA, Kuss AW, Puettmann L, et al. Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am J Hum Genet 2011;89(1):176-82
   PubMed Web of Science ®Google Scholar
• Helander A, Bergstrom J, Freeze HH. Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. Clin Chem 2004;50(5):954-8
   PubMed Web of Science ®Google Scholar
• Carchon HA, Chevigne R, Falmagne JB, Jaeken J. Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. Clin Chem 2004;50(1):101-11
   PubMed Web of Science ®Google Scholar
• Babovic-Vuksanovic D, O'Brien JF. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms. Mol Diagn Ther 2007;11(5):303-11
   PubMed Web of Science ®Google Scholar
• Lefeber DJ, Morava E, Jaeken J. How to find and diagnose a CDG due to defective N-glycosylation. J Inherit Metab Dis 2011;34(4):849-52
   PubMed Web of Science ®Google Scholar
• Guillard M, Morava E, van Delft FL, et al. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II. Clin Chem 2011;57(4):593-602
   PubMed Web of Science ®Google Scholar
• Volker C, De Praeter CM, Hardt B, et al. Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb). Glycobiology 2002;12(8):473-83
   PubMed Web of Science ®Google Scholar
• Kahrizi K, Hu CH, Garshasbi M, et al. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Eur J Hum Genet 2011;19(1):115-17
   PubMed Web of Science ®Google Scholar
• Shrimal S, Ng BG, Losfeld ME, et al. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet 2013;22(22):4638-45
   PubMed Web of Science ®Google Scholar
• Iqbal Z, Shahzad M, Vissers LE, et al. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype. Eur J Hum Genet 2013;21(8):844-9
   PubMed Web of Science ®Google Scholar
• Qiao Y, Mondal K, Trapani V, et al. Variant ATRX Syndrome with dysfunction of ATRX and MAGT1 genes. Hum Mutat 2013;35:58-62
   Web of Science ®Google Scholar
• Garshasbi M, Kahrizi K, Hosseini M, et al. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family. Am J Med Genet A 2011;155A(8):1976-80
   PubMed Web of Science ®Google Scholar
• Ng BG, Buckingham KJ, Raymond K, et al. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet 2013;92(4):632-6
   PubMed Web of Science ®Google Scholar
• Mohamed M, Ashikov A, Guillard M, et al. Intellectual disability and bleeding diathesis due to deficient CMP-sialic acid transport. Neurology 2013;81(7):681-7
   PubMed Web of Science ®Google Scholar
• Tan J, Dunn J, Jaeken J, Schachter H. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet 1996;59(4):810-17
   PubMed Web of Science ®Google Scholar
• Guillard M, Morava E, de Ruijter J, et al. B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvement. J Pediatr 2011;159(6):1041-3. e1042
   PubMed Web of Science ®Google Scholar
• Morava E, Vodopiutz J, Lefeber DJ, et al. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 2012;130(4):e1034-9
   PubMed Web of Science ®Google Scholar
• Riess S, Reddihough DS, Howell KB, et al. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings. Mol Genet Metab 2013;110(1-2):170-5
   PubMed Web of Science ®Google Scholar
• Sun L, Eklund EA, Van Hove JL, et al. Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient. Am J Med Genet A 2005;137(1):22-6
   PubMedGoogle Scholar
• Drijvers JM, Lefeber DJ, de Munnik SA, et al. Skeletal dysplasia with brachytelephalangy in a patient with a congenital disorder of glycosylation due to ALG6 gene mutations. Clin Genet 2010;77(5):507-9
   PubMed Web of Science ®Google Scholar
• Ondruskova N, Vesela K, Hansikova H, et al.1-CDG in adult siblings with novel mutations. Mol Genet Metab 2012;107(4):760-2
   PubMed Web of Science ®Google Scholar
• Finlayson S, Palace J, Belaya K, et al. Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1. J Neurol Neurosurg Psychiatry 2013;84(10):1119-25
   PubMed Web of Science ®Google Scholar
• Wurde AE, Reunert J, Rust S, et al. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease. Mol Genet Metab 2012;105(4):634-41
   PubMed Web of Science ®Google Scholar
• Molinari F, Foulquier F, Tarpey PS, et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet 2008;82(5):1150-7
   PubMed Web of Science ®Google Scholar
• de Cock P, Jaeken J. MGAT2 deficiency (CDG-IIa): the Life of J. Biochim Biophys Acta 2009;1792(9):844-6
   PubMed Web of Science ®Google Scholar
• de la Morena-Barrio ME, Hernandez-Caselles T, Corral J, et al. GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients. Orphanet J Rare Dis 2013;8:170
   PubMed Web of Science ®Google Scholar
• Krasnewich D, O'Brien K, Sparks S. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia). Am J Med Genet C Semin Med Genet 2007;145C(3):302-6
   PubMed Web of Science ®Google Scholar
• Stibler H, Blennow G, Kristiansson B, et al. Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatry 1994;57(5):552-6
   PubMed Web of Science ®Google Scholar
• Coman D, McGill J, MacDonald R, et al. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype. J Clin Neurosci 2007;14(7):668-72
   PubMed Web of Science ®Google Scholar
• Linssen M, Mohamed M, Wevers RA, et al. Thrombotic complications in patients with PMM2-CDG. Mol Genet Metab 2013;109(1):107-11
   PubMed Web of Science ®Google Scholar
• Perez-Duenas B, Garcia-Cazorla A, Pineda M, et al. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Eur J Paediatr Neurol 2009;13(5):444-51
   PubMed Web of Science ®Google Scholar
• Westphal V, Kjaergaard S, Davis JA, et al. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metab 2001;73(1):77-85
   PubMed Web of Science ®Google Scholar
• Janssen MCH, de Kleine RH, van den Berg AP, et al. Successful liver transplantation and long-term follow-up in a patient with MPI-CDG. Pediatrics 2014; In press
   Web of Science ®Google Scholar
• Helander A, Jaeken J. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. Clin Chim Acta 2014; In press
   PubMed Web of Science ®Google Scholar
• Cantagrel V, Lefeber DJ, Ng BG, et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 2010;142(2):203-17
   PubMed Web of Science ®Google Scholar
• Morava E, Wevers RA, Cantagrel V, et al. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain 2010;133(11):3210-20
   PubMedGoogle Scholar
• Kapusta L, Zucker N, Frenckel G, et al. From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG). Heart Fail Rev 2013;18(2):187-96
   PubMed Web of Science ®Google Scholar
• Barone R, Aiello C, Race V, et al. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Ann Neurol 2012;72(4):550-8
   PubMed Web of Science ®Google Scholar
• Lefeber DJ, Schonberger J, Morava E, et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet 2009;85(1):76-86
   PubMed Web of Science ®Google Scholar
• Mohamed M, Kouwenberg D, Gardeitchik T, et al. Metabolic cutis laxa syndromes. J Inherit Metab Dis 2011;34(4):907-16
   PubMed Web of Science ®Google Scholar
• Rymen D, Keldermans L, Race V, et al. COG5-CDG: expanding the clinical spectrum. Orphanet J Rare Dis 2012;7:94
   PubMed Web of Science ®Google Scholar
• Morava E, Wopereis S, Coucke P, et al. Defective protein glycosylation in patients with cutis laxa syndrome. Eur J Hum Genet 2005;13(4):414-21
   PubMed Web of Science ®Google Scholar
• Mohamed M, Guillard M, Wortmann SB, et al. Clinical and diagnostic approach in unsolved CDG patients with a type 2 transferrin pattern. Biochim Biophys Acta 2011;1812(6):691-8
   PubMed Web of Science ®Google Scholar
• Hucthagowder V, Morava E, Kornak U, et al. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet 2009;18(12):2149-65
   PubMed Web of Science ®Google Scholar
• Foulquier F, Amyere M, Jaeken J, et al. TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet 2012;91(1):15-26
   PubMed Web of Science ®Google Scholar
• Calvo PL, Pagliardini S, Baldi M, et al. Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx. J Inherit Metab Dis 2008;31(Suppl 2):S437-40
   PubMedGoogle Scholar
• Rymen D, Peanne R, Millon MB, et al. MAN1B1 Deficiency: an Unexpected CDG-II. PLoS Genet 2013;9(12):e1003989
   PubMed Web of Science ®Google Scholar
• Van Scherpenzeel M, Timal S, Rymen D, et al. Diagnostic serum glycosylation profile in patients with intellectual disability due to MAN1B1 deficiency. Brain 2014; In press
   PubMed Web of Science ®Google Scholar
• Stojkovic T, Vissing J, Petit F, et al. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 2009;361(4):425-7
   PubMed Web of Science ®Google Scholar
• Tegtmeyer LC, Rust S, van Scherpenzeel M, et al. Phosphoglucomutase 1 deficiency – clinical phenotype, molecular basis and treatment. N Engl J Med 2014; In press
   PubMedGoogle Scholar
• Timal S, Hoischen A, Lehle L, et al. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet 2012;21(19):4151-61
   PubMed Web of Science ®Google Scholar
• Belaya K, Finlayson S, Slater CR, et al. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet 2012;91(1):193-201
   PubMed Web of Science ®Google Scholar
• Sparks SE. Inherited disorders of glycosylation. Mol Genet Metab 2006;87(1):1-7
   PubMed Web of Science ®Google Scholar
• Truin G, Guillard M, Lefeber DJ, et al. Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia. Mol Genet Metab 2008;94(4):481-4
   PubMed Web of Science ®Google Scholar
• de Lonlay P, Seta N. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta 2009;1792(9):841-3
   PubMed Web of Science ®Google Scholar
• Thiel C, Korner C. Therapies and therapeutic approaches in Congenital Disorders of Glycosylation. Glycoconj J 2013;30(1):77-84
   PubMed Web of Science ®Google Scholar
• Panneerselvam K, Freeze HH. Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. J Biol Chem 1996;271(16):9417-21
   PubMed Web of Science ®Google Scholar
• Hardre R, Salmon L. Competitive inhibitors of yeast phosphoglucose isomerase: synthesis and evaluation of new types of phosphorylated sugars from the synthon D-arabinolactone-5-phosphate. Carbohydr Res 1999;318(1-4):110-15
   PubMed Web of Science ®Google Scholar
• Liem YS, Bode L, Freeze HH, et al. Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib. Nat Clin Pract Gastroenterol Hepatol 2008;5(4):220-4
   PubMedGoogle Scholar
• Bubel S, Peters V, Klein C, et al. [CDG (congenital disorders of glycosylation). Differential hereditary ataxia in adulthood diagnosis]. Nervenarzt 2002;73(8):754-60
   PubMed Web of Science ®Google Scholar